Figure 4.

Pro apoptotic effects of osteosarcoma treatment with cMSCs associated with rhBMP2. Markers expression of osteosarcoma treatment with cMSCs and cMSCs treated with rhBMP2 (5 nM) for 120 after treatment analyzed by flow cytometry. Statistical differences were obtained by analysis of variance (*** p < 0.001, ** p < 0.01).

Grassi Rici et al. BMC Veterinary Research 2012 8:17   doi:10.1186/1746-6148-8-17
Download authors' original image